<?xml version='1.0' encoding='utf-8'?>
<document id="26808357"><sentence text="Strategy for the Prediction of Steady-State Exposure of Digoxin to Determine Drug-Drug Interaction Potential of Digoxin With Other Drugs in Digitalization Therapy."><entity charOffset="56-63" id="DDI-PubMed.26808357.s1.e0" text="Digoxin" /><entity charOffset="112-119" id="DDI-PubMed.26808357.s1.e1" text="Digoxin" /><pair ddi="false" e1="DDI-PubMed.26808357.s1.e0" e2="DDI-PubMed.26808357.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26808357.s1.e0" e2="DDI-PubMed.26808357.s1.e1" /></sentence><sentence text="Digoxin, a narrow therapeutic index drug, is widely used in congestive heart failure"><entity charOffset="0-7" id="DDI-PubMed.26808357.s2.e0" text="Digoxin" /></sentence><sentence text=" However, the digitalization therapy involves dose titration and can exhibit drug-drug interaction" /><sentence text=" Ctrough versus area under the plasma concentration versus time curve in a dosing interval of 24 hours (AUC0-24h) and Cmax versus AUC0-24h for digoxin were established by linear regression" /><sentence text=" The predictions of digoxin AUC0-24h values were performed using published Ctrough or Cmax with appropriate regression lines" /><sentence text=" The fold difference, defined as the quotient of the observed/predicted AUC0-24h values, was evaluated" /><sentence text=" The mean square error and root mean square error, correlation coefficient (r), and goodness of the fold prediction were used to evaluate the models" /><sentence text=" Both Ctrough versus AUC0-24h (r = 0" /><sentence text="9215) and Cmax versus AUC0-24h models for digoxin (r = 0"><entity charOffset="42-49" id="DDI-PubMed.26808357.s9.e0" text="digoxin" /></sentence><sentence text="7781) showed strong correlations" /><sentence text=" Approximately 93" /><sentence text="8% of the predicted digoxin AUC0-24h values were within 0" /><sentence text="76-fold to 1" /><sentence text="25-fold difference for Ctrough model" /><sentence text=" In sharp contrast, the Cmax model showed larger variability with only 51" /><sentence text="6% of AUC0-24h predictions within 0" /><sentence text="76-1" /><sentence text="25-fold difference" /><sentence text=" The r value for observed versus predicted AUC0-24h for Ctrough (r = 0" /><sentence text="9551; n = 177; P &lt; 0" /><sentence text="001) was superior to the Cmax (r = 0" /><sentence text="6134; n = 275; P &lt; 0" /><sentence text="001) model" /><sentence text=" The mean square error and root mean square error (%) for the Ctrough model were 11" /><sentence text="95% and 16" /><sentence text="2% as compared to 67" /><sentence text="17% and 42" /><sentence text="3% obtained for the Cmax model" /><sentence text=" Simple linear regression models for Ctrough/Cmax versus AUC0-24h were derived for digoxin"><entity charOffset="83-90" id="DDI-PubMed.26808357.s29.e0" text="digoxin" /></sentence><sentence text=" On the basis of statistical evaluation, Ctrough was superior to Cmax model for the prediction of digoxin AUC0-24h and can be potentially used in a prospective setting for predicting drug-drug interaction or lack of it" /><sentence text="" /></document>